Related Experiment Video
Updated: May 28, 2025

00:10
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
Author Correction: Immunoinformatics approaches in developing a novel multi-epitope chimeric vaccine protective
Abhigyan Choudhury1, Pawan Kumar2, Hiba-Allah Nafdi3
1Independent Researcher, Asansol, West Bengal, 713 305, India. abhigyan6531@gmail.com.
Scientific Reports
|February 13, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Cross-reactivity
30.9K
Overview
30.9K
Hybridoma Technology
14.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.0K

